Jian Xu

发表

Albumin‐Mediated Delivery of Bioactive Peptides for Pancreatic Cancer Therapy

Y. Zhen, Yue Du, B. Shang, 2020 .

Enediyne-activated, EGFR-targeted human β-defensin 1 has therapeutic efficacy against non-small cell lung carcinoma

Jia‐Lin Wang, Kunkun Zhu, Jian Xu, 2018, Laboratory Investigation.

The role of T-cell immunoglobulin- and mucin-domain-containing molecule-3 polymorphisms in idiopathic thrombocytopenic purpura.

F. Xue, Jing Ge, Jian Xu, 2009, Human immunology.

Advances and challenges in the treatment of esophageal cancer

Y. Zhen, Xiujun Liu, Jian Xu, 2021, Acta pharmaceutica Sinica. B.

Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis

W. Tan, Chen Wu, D. Lin, 2011, Molecular Carcinogenesis.

Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma.

W. Tan, Chen Wu, D. Lin, 2013, Human molecular genetics.

Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.

W. Tan, Chen Wu, D. Lin, 2011, Cancer research.

Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients.

Hongbing Shen, Chen Wu, D. Lin, 2010, Cancer research.

Functional FEN1 polymorphisms are associated with DNA damage levels and lung cancer risk

W. Tan, Chen Wu, D. Lin, 2009, Human mutation.

An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacy

Y. Zhen, Jian Xu, Yi Li, 2015, Oncotarget.

Risk of Genome-Wide Association Study–Identified Genetic Variants for Colorectal Cancer in a Chinese Population

W. Tan, Chen Wu, D. Lin, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations

Wen Tan, Dianke Yu, Tangchun Wu, 2011, Nature Genetics.

CDK11p110 plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target

X. Tian, Q. Kan, Zhiheng Yang, 2019, Cell cycle.

Enhancing the Therapeutic Efficacy of Gefitinib in Human Non-Small-Cell Lung Cancer through Drug Combination.

Xiujun Liu, Yue Du, Jian Xu, 2021, Molecular pharmaceutics.

CircRNAs as biomarkers of cancer: a meta-analysis

Jian Xu, Huijian Wu, Wen Bai, 2018, BMC Cancer.

EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis

Y. Zhen, Jia‐Lin Wang, Qing-fang Miao, 2018, Acta Pharmacologica Sinica.

Intensive fibrosarcoma-binding capability of the reconstituted analog and its antitumor activity

Y. Zhen, Yue Du, Hong-Fei Yi, 2017, Drug delivery.

Recombinant EGFR/MMP‐2 bi‐targeted fusion protein markedly binding to non‐small‐cell lung carcinoma and exerting potent therapeutic efficacy

Y. Zhen, Yue Du, Jian Xu, 2017, Pharmacological research.

Ubiquitin-like prokaryotic MoaD as a fusion tag for expression of heterologous proteins in Escherichia coli

Jian Xu, Xin Wang, Zheng Yan, 2014, BMC Biotechnology.

Prokaryotic Ubiquitin-Like ThiS Fusion Enhances the Heterologous Protein Overexpression and Aggregation in Escherichia coli

Y. Ge, Jian Xu, Zheng Yan, 2013, PloS one.

Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis

Chen Wu, D. Lin, Dianke Yu, 2011, Molecular carcinogenesis.

EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis

Y. Zhen, Jia‐Lin Wang, Jian Xu, 2018, Acta Pharmacologica Sinica.